The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

Also called NCT05350124

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
King Abdulaziz University (from the registry)
Registry
  • NCT NCT05350124
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05350124. Randomized; triple masking; primary purpose treatment. Start 2022-11 (anticipated); primary completion 2023-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis
Condition
Restless Legs Syndrome
Condition
End Stage Renal Disease
Intervention (Drug)
Ascorbic acid
Intervention (Drug)
Tocopherol
Intervention (Drug)
Placebo capsule
Intervention (Drug)
Placebo capsule
Lead sponsor
King Abdulaziz University (class: other)

Record details

Record id
cardio:ct-nct05350124
Content hash
6bf0bd995a8968aa9c909e5d03ebe88e05254169a3a590a89f3a1810c22d8817